fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ECC 2013: Late Breaking Clinical Trials: EXPERT-C Trial results

Written by | 15 Nov 2013

Report by Esther Drain – Cetuximab resulted in a significant improvement in survival in TP53 WT, high-risk Rectal Cancer.

Press Release – Future doctors unprepared to manage pain – one of the most common problems they will encounter in clinical practice, expert group warns

Written by | 11 Oct 2013

First ever Europe-wide study reveals that even when undergraduate medical students take a compulsory course on pain, they still only receive on average 12 hours’ training

ESMO WCGC 2013 Report – Hot topics in Colon Cancer

Written by | 12 Sep 2013

by Pam Harrison – MSI status has clear prognostic value in stage II CRC Julien Taieb, MD, PhD, University of Paris Descartes, Paris, France Microsatellite instability (MSI), a… read more.

Chemotherapy-refractory large B-cell lymphomas reprogrammed to respond to Azacitidine

Written by | 29 Aug 2013

FDA Highlights by Bruce Sylvester – Researchers report from a phase I clinical trial report that diffuse, large B-cell lymphomas (DLBCLs) resistant to chemotherapy have been successfully reprogrammed… read more.

ASCO Interview 2013: Matthias Holdhoff discusses his presentation on primary CNS lymphoma

Written by | 25 Jul 2013

Matthias Holdhoff, MD, PHD, Assistant Professor of Oncology.  The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

ASCO 2013 – Cancer services in the United Kingdom: Improving nicely

Written by | 25 Jun 2013

by Elizabeth C. Smyth, MB, BCh, MSc, and David Cunningham, MD, FRCP, FMedSci – In 2000, in order to optimise service provision for patients with cancer, 34 “Cancer… read more.

ASCO 2013 – Landmark studies offer new hope for reducing cervical cancer deaths worldwide, first therapies for two rare cancers and treatment advances for breast, brain cancers

Written by | 24 Jun 2013

CHICAGO – Five pivotal studies were released today ahead of the plenary session of the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).

ASCO 2013 – The evolution of fellowship training: Concurrent oncology and palliative care

Written by | 24 Jun 2013

by Jamie Von Roenn, MD, and Charles von Gunten, MD, PhD – The call to integrate palliative care practices and principles into comprehensive cancer care, not as something… read more.

ASCO opens 49th Annual Meeting urging more federal funding for research

Written by | 21 Jun 2013

The American Society of Clinical Oncology (ASCO) kicked off its 49th Annual Meeting with leaders urging all stakeholders in cancer care to vigorously oppose cuts to vital US… read more.

ASCO completes electronic data sharing standard for breast cancer treatment effort in conjunction with developing CancerLinQ™

Written by | 20 Jun 2013

CHICAGO – The American Society of Clinical Oncology (ASCO) has completed the first phase in developing several sets of interoperability standards for cancer care data and overcoming the… read more.

ASCO 2013 – Important advances in treatment for multiple aggressive cancers, and new insight on HPV-related cancer risk

Written by | 20 Jun 2013

CHICAGO – New advances against melanoma, ovarian cancer, and colorectal cancer care were presented today at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)…. read more.

ASCO 2013 Report – Advanced lung cancer with dysfunctional ALK gene responds to targeted therapy

Written by | 12 Jun 2013

by Bruce Sylvester – Patients with an advanced kind of lung cancer and a dysfunctional ALK gene have achieved better outcomes with the targeted investigative therapy crizotinib rather… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.